Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Peijia Medical's gross profit for the
six
months ended in Dec. 2025 was $33.9 Mil. Peijia Medical's gross profit for the trailing twelve months (TTM) ended in Dec. 2025 was $76.7 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Peijia Medical's gross profit for the
six
months ended in Dec. 2025 was $33.9 Mil. Peijia Medical's Revenue for the
six
months ended in Dec. 2025 was $51.0 Mil. Therefore, Peijia Medical's Gross Margin % for the quarter that ended in Dec. 2025 was 66.32%.
Peijia Medical had a gross margin of 66.32% for the quarter that ended in Dec. 2025 => Durable competitive advantage
During the past 8 years, the highestGross Margin % of Peijia Medical was 73.76%. The lowest was 64.24%. And the median was 70.06%.
Peijia Medical (OTCPK:PEJMF) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Peijia Medical had a gross margin of 66.32% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Peijia Medical Gross Profit Related Terms
Peijia Medical Gross Profit Historical Data
* Premium members only.
The historical data trend for Peijia Medical's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Peijia Medical's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Peijia Medical Gross Profit vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Peijia Medical's Gross Profit distribution charts can be found below:
* The bar in red indicates where Peijia Medical's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $76.7 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Peijia Medical (PEJMF) has a Gross Profit of $76.7 Mil as of Dec. 2025. Gross Profit equals net sales less total cost of goods sold. View historical data on Peijia Medical and its competitors.
Is Peijia Medical's Gross Profit too high?
Peijia Medical's current Gross Profit is $76.7 Mil. Overall, Peijia Medical has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Peijia Medical's Gross Profit compare to ABT and SYK?
Peijia Medical's Gross Profit of $76.7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Medical Devices & Instruments company?
A good Gross Profit depends on the Medical Devices & Instruments industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Peijia Medical and its competitors. Peijia Medical's current Gross Profit is $76.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peijia Medical stock overvalued right now?
Peijia Medical (PEJMF) has a current Gross Profit of $76.7 Mil. The stock's GF Value™ is $2.45, compared to a current price of $1.39 — trading 43.4% below its estimated fair value. The current Gross Profit is $76.7 Mil. Peijia Medical's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Peijia Medical (PEJMF), the current Gross Profit is $76.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Peijia Medical (PEJMF) Overvalued in 2026?
Based on GuruFocus' analysis, Peijia Medical stock appears to be undervalued.
The current stock price of $1.39 is trading 43.4% below its estimated GF Value™ of $2.45.
Key valuation signals for PEJMF:
Gross Profit: $76.7 Mil
GF Value™: $2.45 vs. price of $1.39 (43.4% below fair value)
No single metric tells the full story. See the PEJMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Peijia Medical Ltdis a provider of inventive medical products and solutions. It focuses on the high-growth interventional procedural medical device market in China. Its products and product candidates target large, fast-growing and under-penetrated markets with high entry barriers, including the transcatheter valve therapeutic medical device market and the neurointerventional procedural medical device market. The Company's product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates spanning three key business segments: Transcatheter Valve Therapeutic Business, Future Technology Business and Neurointerventional Business.
80GF Score
Get the complete analysis for PEJMF
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PEJMF has been successfully added to your 
